Gerald Durrell’s Centenary: a year of celebrations starts today
January 10, 2025
Zebra dies after ‘incident’with rhino at zoo
January 10, 2025
The FINANCIAL -- UCB and AstraZeneca announced on September 28 that they have entered into a partnership to register and commercialize UCB's...
The FINANCIAL -- Abbott on September 28 announced a definitive agreement with the Solvay Group for Abbott to acquire Solvay's pharmaceuticals business...
The FINANCIAL -- At the 45th Annual Meeting of the European Association for the Study of Diabetes (EASD) Bayer Diabetes...
The FINANCIAL -- At the 45th Annual Meeting of the European Association for the Study of Diabetes (EASD) Bayer Diabetes...
The FINANCIAL -- Eli Lilly and Company (NYSE: LLY) has been given a 100 percent rating on the Human Rights...
The FINANCIAL -- Amgen (Nasdaq: AMGN) on September 21 announced detailed results from a Phase 3 trial evaluating denosumab administered subcutaneously versus...
The FINANCIAL -- Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) announced on September 21 that it has been listed for the third consecutive...
The FINANCIAL -- Gilead Sciences, Inc. (Nasdaq:GILD) on September 13 announced the publication of data from DAR-311 (DORADO), a Phase III clinical...
The FINANCIAL -- Abbott announced on September 14 that it has received marketing authorization from the European Commission for once-daily dosing of...
The FINANCIAL -- Amgen Inc. (Nasdaq: AMGN) on September 13 announced the presentation of data highlighting the links between medication satisfaction, adherence...
The FINANCIAL -- 53% of patients with H5N1 infection survived when treated with Tamiflu compared with 12% of untreated patients.
The FINANCIAL -- Alcon (NYSE:ACL) announced on September 13 that it has entered into a definitive agreement to acquire ESBATech AG, a...
The FINANCIAL -- Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) announced on August 3o that the investigational anti-Xa intravenous anticoagulant otamixaban...
The FINANCIAL -- Abbott (NYSE: ABT) on August 31 announced at the European Society of Cardiology Congress the widespread availability of its...
The FINANCIAL -- AstraZeneca on August 30 announced results from the phase III head to head trial, PLATO (A Study of Platelet...